MARC Record from marc_columbia

LEADER: 16152cam a22004094a 4500
001 4328247
005 20221102195027.0
008 030807s2003 nyua b 101 0 eng
010 $a 2003060289
020 $a0306477556
035 $a(OCoLC)ocm52901200
035 $a(NNC)4328247
035 $a4328247
040 $aDLC$cDLC$dCUX$dC#P$dCLU$dOrLoB-B
042 $apcc
050 00 $aQP562.T7$bD48 2003
082 00 $a572.8/4$222
245 00 $aDevelopments in tryptophan and serotonin metabolism /$cedited by Graziella Allegri [and others].
260 $aNew York :$bKluwer Academic/Plenum,$c2003.
300 $axix, 774 pages :$billustrations ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAdvances in experimental medicine and biology ;$vv. 527
504 $aIncludes bibliographical references and index.
505 00 $tMetabolism to function - an odyssey with tryptophan /$rO. Hayaishi -- $g1.$tTryptophan Catabolism and Immunobiology -- $tRole of IDO activation in anti-microbial defense in human native astrocytes /$rC. Oberdorfer, O. Adams, C. R. MacKenzie, C. J. A. De Groot and W. Daubener -- $tTryptophan catabolism and T cell response /$rA. L. Mellor, D. Munn, P. Chandler, D. Keskin, T. Johnson, B. Marshall, K. Jhaver and B. Baban -- $tQuinolinic acid up-regulates chemokine production and chemokine receptor expression in astrocytes /$rJ. Croitoru-Lamoury, G. J. Guillemin, D. Dormont and B. J. Brew -- $tTryptophan catabolism in nonobese diabetic mice /$rU. Grohmann, F. Fallarino, R. Bianchi, C. Vacca, C. Orabona, M. L. Belladonna, M. C. Fioretti and P. Puccetti -- $tMacrophage activating properties of the tryptophan catabolite picolinic acid /$rM. C. Bosco, A. Rapisarda, G. Reffo, S. Massazza, S. Pastorino and L. Varesio -- $tRegulation of IDO-mediated bacteriostasis in macrophages: role of antibiotics and anti-inflammatory agents /$rC. R. MacKenzie, D. Worku and W. Daubener -- $tTryptophan degradation during and after gestation /$rK. Schrocksnadel, B. Widner, A. Bergant, G. Neurauter, H. Schrocksnadel and D. Fuchs -- $tIncreased mRNA expression of kynurenine pathway enzymes in human placentae exposed to bacterial endotoxin /$rU. Manuelpillai, T. Nicholls, E. M. Wallace, D. J. Phillips, G. Guillemin and D. Walker -- $tExpression of indoleamine 2,3-dioxygenase in carcinoma of human endometrium and uterine cervix /$rP. Sedlmayr, M. Semlitsch, D. Gebru, E. Karpf, O. Reich, T. Tang, R. Wintersteiger, O. Takikawa and G. Dohr -- $tThe mechanism of interferon-[gamma] induced anti Toxoplasma gondii by indoleumine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues /$rS. Fujigaki, M. Takemura, H. Hamakawa, M. Seishima and K. Saito -- $tExpression of the kynurenine pathway enzymes in human microglia and macrophages /$rG. J. Guillemin, D. G. Smith, G. A. Smythe, P. J. Armati and B. J. Brew -- $tIDO (indolamine 2,3-dioxygenase) expression and function in the CNS /$rE. Kwidzinski, J. Bunse, A. D. Kovac, O. Ullrich, F. Zipp, R. Nitsch and I. Bechmann -- $g2.$tKynurenines in Neurobiology -- $tNeurokynurenines (NEKY) as common neurochemical links of stress and anxiety /$rI. P. Lapin -- $tStudies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage /$rF. Moroni, R. Carpenedo, A. Cozzi, E. Meli, A. Chiarugi and D. E. Pellegrini-Giampietro -- $t3-Hydroxykynurenine and quinolinate: Pathogenic synergism in early grade Huntington's disease? /$rP. Guidetti and R. Schwarcz -- $tAccumulation of quinolinic acid with neuroinflammation: Does it mean excitotoxicity? /$rT. P. Obrenovitch and J. Urenjak -- $tKynurenic acid and schizophrenia /$rS. Erhardt, L. Schwieler and G. Engberg -- $tQuinolinic acid in the pathogenesis of Alzheimer's disease /$rG. J. Guillemin, K. R. Williams, D. G. Smith, G. A. Smythe, J. Croitoru-Lamoury and B. J. Brew -- $tKynurenine metabolism in central nervous system in experimental chronic renal failure /$rJ. Topczewska-Bruns, D. Pawlak, A. Tankiewicz, E. Chabielska and W. Buczko -- $tT cell apoptosis by kynurenines /$rF. Fallarino, U. Grohmann, C. Vacca, C. Orabona, A. Spreca, M. C. Fioretti and P. Puccetti -- $tNeurokynurenines - seizures or/and anxiety in children with epilepsy? /$rN. V. Melnikova -- $g3.$tTryptophan and Mental Disorders -- $tEnzymatic depletion of serotonin in vivo and its consequences /$rK. Takai, E. Ogiso-Nakamaru, H. Miyamoto, K. Hamada and K. Tsukada -- $tTryptophan Modulation and Cognition /$rW. J. Riedel, S. Sobczak and J. A. J. Schmitt -- $tTryptophan, serotonin and human social behavior /$rD. S. Moskowitz, G. Pinard, D. C. Zuroff, L. Annable and S. N. Young -- $tRole of brain tryptophan and serotonin in secondary anorexia /$rF. Rossi-Fanelli and A. Laviano -- $tPlasma leptin, insulin and free tryptophan contribute to cytokine-induced anorexia /$rT. Sato, A. Laviano, M. M. Meguid and F. Rossi-Fanelli -- $g4.$tPathological and Clinical Aspects -- $tRecent advances in physiological and pathological significance of tryptophan-NAD metabolites: Roles of poly(ADP-ribose) and cyclic ADP-ribose in insulin secretion and diabetogenesis /$rH. Okamoto -- $tThe endogenous formation of highly chlorinated tetrahydro-[beta]-carbolines as a possible causative mechanism in idiopathic Parkinson's disease /$rW. Kochen, D. Kohlmuller, P. De Biasi and R. Ramsay -- $tExperimental evaluation of an altered tryptophan metabolism in fibromyalgia /$rM. J. Schwarz, M. Offenbaecher, A. Neumeister and M. Ackenheil -- $tAge-related nuclear cataract and indoleamine 2,3-dioxygenase-initiated tryptophan metabolism in the human lens /$rO. Takikawa, R. J. W. Truscott, M. Fukao and S. Miwa -- $tKynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment /$rC. M. Forrest, A. Kennedy, T. W. Stone, N. Stoy and L. G. Darlington -- $tInduction of cytochrome P450 |A| and |B| by photooxidized tryptophan in transformed human keratinocytes /$rR. K. Sindhu, F. E. Wagner and Y. Kikkawa -- $tPrognostic value of tryptophan load test followed by serum kynurenine determination. It's comparison with pyridoxal-5-phosphate, kynurenine, homocysteine and neopterin amounts /$rV. Rudzite, D. Fuchs, U. Kalnins, E. Jurika, A. Silava, A. Erglis, K. Trusinskis and S. Jegere -- $tEffective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection /$rG. Neurauter, G. Zangerle, B. Widner, G. Quirchmair, M. Sarcletti and D. Fuchs -- $tA clinicobiochemical study of tryptophan and other plasma and urinary amino acids in the family with Hartnup disease /$rD. D. Milovanovic -- $tThe influence of L-tryptophan peroral load on glomerular filtration rate in chronic glomerulonephritis and chronic renal failure /$rA. Martinsons, V. Rudzite, H. Cernevskis, I. Mihailova and Z. Smeltere -- $tNeuropeptide-containing cells in the cortex and striatum of mice with cerebral malaria /$rC. J. Clark, R. S. Phillips and T. W. Stone -- $tTryptophan and quality of life in colorectal cancer /$rA. Huang, D. Fuchs, B. Widner, C. Glover, D. C. Henderson and T. G. Allen-Mersh -- $tEffects of chronic lung inflammation on tryptophan metabolism in piglets /$rD. Melchior, N. Le Floc'h and B. Seve -- $tTumor-induced changes in host metabolism: a possible role for free tryptophan as a marker of neoplastic disease /$rA. Laviano, A. Cascino, M. Muscaritoli, F. Fanfarillo and F. Rossi-Fanelli -- $tKynurenine and neopterin in the aqueous humor of the anterior chamber of the eye and in serum of cataract patients /$rG. Laganovska, A. Martinsons, B. Pitrans, B. Widner and D. Fuchs -- $tMechanism of inhibitor effect of 3-hydroxykynurenine on erythropoiesis in patients with renal insufficiency /$rD. Pawlak, M. Koda, S. Wolczynski, M. Mysliwiec and W. Buczko -- $tThe kynurenine pathway enzymes in healthy and hyperlipidemic rabbits /$rG. Allegri, E. Ragazzi, C. V. L. Costa, L. Caparrotta, M. Biasiolo and S. Vanin -- $tMetabolism of tryptophan along the kynurenine pathway in alloxan diabetic rabbits /$rG. Allegri, D. Zaccarin, E. Ragazzi, G. Froldi, A. Bertazzo and C. V. L. Costa -- $tLevels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease /$rC. M. Forrest, S. R. Gould, L. G. Darlington and T. W. Stone -- $tUpregulation of cytochrome P450 1A2 in chronic renal failure: does oxidized tryptophan play role? /$rR. K. Sindhu and N. D. Vaziri -- $tKidney and liver kynurenine pathway enzymes in chronic renal failure /$rA. Tankiewicz, D. Pawlak, J. Topczewska-Bruns and W. Buczko -- $tCerebral cholinergic neurotransmission in protein and tryptophan-restricted adult rats /$rA. R. Del Angel Meza, I. G. Adame Gonzalez, J. Segura Torres, R. Montes Gonzalez, I. Gonzalez Burgos and C. Beas Zarate -- $g5.$tTryptophan Metabolism and Enzymology -- $tTryptophan pyrrole ring cleavage enzymes in placenta /$rY. Minatogawa, S. Suzuki, Y. Ando, S. Tone and O. Takikawa --
505 80 $tIncrease in conversion of tryptophan to niacin in pregnant rats /$rK. Shibata, T. Fukuwatari, M. Murakami and R. Sasaki -- $tIdentification and expression of [alpha] cDNA encoding human 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (ACMSD): A key enzyme for the tryptophan-niacine pathway and quinolinate hypothesis /$rS.-I. Fukuoka, K. Ishiguro, A. Tanabe, Y. Egashira, H. Sanada, T. Fukuwatari and K. Shibata -- $tKynurenine pathway enzymes in different species of animals /$rG. Allegri, A. Bertazzo, M. Biasiolo, C. V. L. Costa and E. Ragazzi -- $tKynurenine pathway enzymes in guinea pigs /$rG. Allegri, C. V. L. Costa, E. Ragazzi, B. Bertazzo and M. Biasiolo -- $tTryptophan metabolism in rabbits /$rG. Allegri, E. Ragazzi, A. Bertazzo, M. Biasiolo and C. V. L. Costa -- $tTryptophan metabolism along the kynurenine pathway in rats /$rG. Allegri, E. Ragazzi, A. Bertazzo, C. V. L. Costa and R. Rocchi -- $tEnzyme activities along the kynurenine pathway in mice /$rG. Allegri, E. Ragazzi, A. Bertazzo and C. V. L. Costa -- $tTryptophan metabolism via transmination. In vitro amino-transferase assay using dinitrophenylhydrazine method /$rJ. Drsata -- $g6.$tTryptophan Metabolism and Exercise -- $tExercise, fatigue, neurotransmission and the influence of the neuroendocrine axis /$rR. Meeusen and M. F. Piacentini -- $tThe effect of tryptophan deficiency in the brain on rat fatigue levels: a rat model of fatigue reduction /$rT. Yamamoto and E. A. Newsholme -- $tTryptophan metabolism was accelerated by exercise in rat /$rY. Ito, R. Yonekura, K. Maruta, T. Koike, Y. Nakagami, K. Shibata, K. Saito and Y. Nagamura -- $g7.$tMelatonin -- $tMelatonin: detoxification of oxygen and nitrogen-based toxic reactants /$rR. J. Reiter, D. X. Tan, L. C. Manchester, S. Lopez-Burillo, R. M. Sainz and J. C. Mayo -- $tMitochondrial regulation by melatonin and its metabolites /$rD. Acuna-Castroviejo, G. Escames, J. Leon, A. Carazo and H. Khaldy -- $tTherapeutic effect of melatonin on cholestatic liver injury in rats with bile duct ligation /$rY. Ohta, M. Kongo and T. Kishikawa -- $tAntioxidant and cytoprotective activity of indole derivatives related to melatonin /$rM. Mor, G. Spadoni, G. Diamantini, A. Bedini, G. Tarzia, C. Silva, F. Vacondio, M. Rivara, P. V. Plazzi, D. Franceschini, M. Zusso and P. Giusti -- $tStrategies leading to MT[subscript 2] selective melatonin receptor antagonists /$rG. Spadoni, A. Bedini, G. Piersanti, M. Mor, S. Rivara and G. Tarzia -- $tPotassium hexacyanoferrate (III)-mediated fluorometric determination of melatonin /$rH. Iizuka and T. Yajima -- $tMelatonin in plants /$rR. Caniato, R. Filippini, A. Piovan, L. Puricelli, A. Borsarini and E. M. Cappelletti -- $g8.$tPharmacological and Toxicological Aspects -- $tThe enol tautomer of indole-3-pyruvic acid as a biological switch in stress responses /$rB. Bartolini, C. Corniello, A. Sella, F. Somma and V. Politi -- $tRecent developments in marine indole alkaloid synthesis /$rM. Nakagawa, T. Nagata, K. Ono, H. Uchida, T. Watanabe, K. Hatakeyama, M. Akiba, F. Fuwa, M. Arisawa and A. Nishida -- $tModulation of the kynurenine pathway of tryptophan metabolism in search for neuroprotective agents. Focus on kynurenine- 3-hydroxylase /$rR. Pellicciari, L. Amori, G. Costantino, A. Giordani, A. Macchiarulo, L. Mattoli, P. Pevarello, C. Speciale and M. Varasi -- $tTryptophan-derived sulfur-containing phytoalexins - A general overview /$rJ. Ruszkowska and J. T. Wrobel -- $tTowards enantioselective synthesis of tryptophan-derived alkaloids /$rA. Siwicka, A. Zawadzka, K. Wojtasiewicz, J. K. Maurin, A. Leniewski and Z. Czarnocki -- $tNovel bisindole derivatives of catharanthus alkaloids with potential cytotoxic properties /$rJ. Ruszkowska, R. Chrobak, J. T. Wrobel and Z. Czarnocki -- $tAntiproliferative effect of indigoid pigments isolated from human urine /$rM. T. Conconi, P. P. Parnigotto, C. V. L. Costa and G. Allegri -- $tNAD levels in the rat primary cultured hepatocytes affected by peroxisome-proliferators /$rM. Shin, M. Ohnishi, K. Sano and C. Umezawa -- $tThe effects of phthalate esters on the tryptophan-niacin metabolism /$rT. Fukuwatari, S. Ohsaki, Y. Suzuki, S.-I. Fukuoka, R. Sasaki and K. Shibata -- $t5-HT receptors mediating contraction in the rat-tail artery /$rG. Froldi, P. Nicoletti, L. Caparrotta and E. Ragazzi -- $tDietary linoleic acid suppresses gene expression of rat liver [alpha]-amino-[beta]-carboxymuconate-[epsilon]-semialdehyde decarboxylase (ACMSD) and increases quinolinic acid in serum /$rY. Egashira, M. Sato, A. Tanabe, K. Saito, S. Fujigaki and H. Sanada -- $g9.$tAnalytical Aspects -- $tSuitability of tryptophan radiation products as markers for the detection of [gamma]-irradiated protein-rich food /$rK. K. Kleeberg, A. Muller, T. J. Simat and H. Steinhart -- $tPhotochemical properties of kynurenine pathway metabolites and indoleamines /$rK. Goda, K. Amako, R. Kishimoto and Y. Ogiri -- $tHPLC of tryptophan and its metabolites: as OPA derivatives and on the basis of their UV and fluorescence spectra, simultaneously /$rP. Presits and I. Molnar-Perl -- $tECNI GC-MS analysis of picolinic and quinolinic acids and their amides in human plasma, CSF and brain tissue /$rG. A. Smythe, A. Poljak, S. Bustamante, O. Braga, A. Maxwell, R. Grant and P. Sachdev -- $tDrosophila mutants of the kynurenine pathway as a model for ageing studies /$rE. V. Savvateeva-Popova, A. V. Popov, T. Heinemann and P. Riederer -- $tInvolvement of 5-hydroxytryptophan in melanogenesis /$rG. Allegri, S. Vogliardi, A. Bertazzo, C. V. L. Costa, R. Seraglia and P. Traldi -- $tInteraction of 7-azatryptophan and [beta]-(l-azulenyl)-alanine with a nitroxyl radical /$rF. Formaggio, E. Sartori, A. Toffoletti, C. Corvaja, L. Moroder and C. Toniolo -- $tHPLC profiling of Trp-related metabolites in humans /$rE. Marklova, Z. Albahri and M. Nozickova -- $t6-Nitrotryptophan: a specific reaction product of tryptophan residue in human Cu, Zn-SOD treated with peroxynitrite /$rF. Yamakura, T. Matsumoto, H. Taka, T. Fujimura and K. Murayama -- $tBioadhesive topical application of tryptophan derivatives /$rA. Bettero, C. Dal Bosco and M. Gregorio -- $tSerum tryptophan and 5-hydroxytryptophan at birth and during post-partum days /$rN. Carretti, A. Bertazzo, S. Comai, C. V. L. Costa, G. Allegri and F. Petraglia -- $tClosing Remarks /$rR. R. Brown.
650 0 $aTryptophan$xMetabolism$vCongresses.
650 0 $aTryptophan$xPathophysiology$vCongresses.
650 0 $aSerotonin$xMetabolism$vCongresses.
650 12 $aTryptophan$xmetabolism.$0https://id.nlm.nih.gov/mesh/D014364Q000378
650 12 $aTryptophan$xphysiology.$0https://id.nlm.nih.gov/mesh/D014364Q000502
650 12 $aSerotonin$xmetabolism.$0https://id.nlm.nih.gov/mesh/D012701Q000378
650 12 $aSerotonin$xphysiology.$0https://id.nlm.nih.gov/mesh/D012701Q000502
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aAllegri, Graziella,$d1932-$0http://id.loc.gov/authorities/names/n2003013881
830 0 $aAdvances in experimental medicine and biology ;$vv. 527.$0http://id.loc.gov/authorities/names/n42001229
852 00 $boff,hsl$hQP562.T7$iD48 2003